Apart from screening assay development QuickZyme Biosciences also offers assay development and assay services to determine activity of proteases and other enzymes in biological fluids of human or animal origin.

QuickZyme Biosciences builds on a long experience of research on proteolytic enzymes and assays in the field of coagulation, fibrinolysis, tumor biology and bone- and cartilage degradation. We have developed a variety of kits and custom made assays for pharmaceutical, biotech and life science companies, such as GE Healthcare, Sigma Aldrich, EMD, Galapagos and Pfizer.